ANTG/LinkedIn
Mar 21, 2026, 19:37
Endometriosis and the Endocannabinoid System – ANTG
Australian Natural Therapeutics Group (ANTG) shared a post on LinkedIn:
“What does the research say about endometriosis and the endocannabinoid system?
Join Justin Sinclair (PhD candidate, NICM Health Research Institute, Chief Scientific Officer, ANTG) as he presents emerging research into medicinal cannabis and its role in endometriosis and chronic pelvic pain.
We’ll explore:
- The endocannabinoid system and its role in symptom regulation
- Real-world patient insights
- Emerging research evidence
Supported by Canview
25 March | 6pm (AEST)
Register via the link.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 17, 2026, 04:19WHO Raises Alarm Over Global Burden of Child Marriage
-
Apr 17, 2026, 04:11Sign Up for Our Latest BFS Insights Webinar – British Fertility Society
-
Apr 17, 2026, 03:43Chantelle Pereira: Endometriosis Paper Highlights Diagnostic Delays and Gaps in Patient Care
-
Apr 17, 2026, 03:35Tal Varsano: Plasma Proteomic Signature of the Human Menstrual Cycle
-
Apr 17, 2026, 03:30Vacancy for a Friendly Senior Embryologist in Berlin, Germany – ESHRE
-
Apr 17, 2026, 03:05Clinical Study Supports Continued IVF After Unsuccessful First Transfer – RBMO
-
Apr 17, 2026, 02:57Standing Together for Black Maternal Health Week – ACOG
-
Apr 16, 2026, 17:24No Difference Between Natural and Artificial Cycles in Endometrium Cases – RBMO
-
Apr 16, 2026, 17:20Marco Zaccaria: Recognizing Innovation in Adenomyosis Treatment